Chemical Compound

(2~{S},3~{S},4~{S})-2-[(1~{R})-2-azanyl-1-[(2~{S},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-methoxy-4-oxidanyl-oxolan-2-yl]-2-oxidanylidene-ethoxy]-3,4-bis(oxidanyl)-~{N}-[(3~{S})-2-oxidanylideneazepan-3-yl]-3,4-dihydro-2~{H}-pyran-6-carboxamide

CAS Registry Number 102770-00-3
返回搜索 申请报价
(2~{S},3~{S},4~{S})-2-[(1~{R})-2-azanyl-1-[(2~{S},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-methoxy-4-oxidanyl-oxolan-2-yl]-2-oxidanylidene-ethoxy]-3,4-bis(oxidanyl)-~{N}-[(3~{S})-2-oxidanylideneazepan-3-yl]-3,4-dihydro-2~{H}-pyran-6-carboxamide 结构式
Primary record

(2~{S},3~{S},4~{S})-2-[(1~{R})-2-azanyl-1-[(2~{S},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-methoxy-4-oxidanyl-oxolan-2-yl]-2-oxidanylidene-ethoxy]-3,4-bis(oxidanyl)-~{N}-[(3~{S})-2-oxidanylideneazepan-3-yl]-3,4-dihydro-2~{H}-pyran-6-carboxamide

库存
9,394 克
纯度
98.7 %
CAS
102770-00-3

化合物标识与属性

CAS
102770-00-3
PubChem CID
5487121
SMILES
CO[C@H]1[C@H]([C@@H](O[C@@H]1[C@H](C(=O)N)O[C@@H]2[C@H]([C@H](C=C(O2)C(=O)N[C@H]3CCCCNC3=O)O)O)N4C=CC(=O)NC4=O)O
Canonical SMILES
CO[C@H]1[C@@H](O)[C@H](n2ccc(=O)[nH]c2=O)O[C@@H]1[C@@H](O[C@H]1OC(C(=O)N[C@H]2CCCCNC2=O)=C[C@H](O)[C@@H]1O)C(N)=O

名称与同义词

  • Capuramycin
  • Antibiotic 446S3-1
  • RefChem:123344
  • 624X0OXY6Y
  • antibiotic 446-S3-1
  • CHEMBL96695
  • AC1NUP56
  • UNII-624X0OXY6Y
  • DTXSID501318180
  • 102770-00-3
  • SCHEMBL14598937
  • GTPL13471
  • BRN 5210055
  • CHEBI:221360
  • DTXCID201747968
  • C23H31N5O12
  • BBF-00216
  • BDBM50135599
  • A-500359 B
  • A-500359B
  • C23-H31-N5-O12
  • CID5487121
  • 446S3-1
  • LS-16347
  • J358.667G
  • (2S,3S,4S)-2-[(1R)-2-amino-1-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-3-methoxyoxolan-2-yl]-2-oxoethoxy]-3,4-dihydroxy-N-[(3S)-2-oxoazepan-3-yl]-3,4-dihydro-2H-pyran-6-carboxamide
  • (2~{S},3~{S},4~{S})-2-[(1~{R})-2-azanyl-1-[(2~{S},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-methoxy-4-oxidanyl-oxolan-2-yl]-2-oxidanylidene-ethoxy]-3,4-bis(oxidanyl)-~{N}-[(3~{S})-2-oxidanylideneazepan-3-yl]-3,4-dihydro-2~{H}-pyran-6-carboxamide
  • (2S,3S,4S)-2-[(1R)-2-amino-1-[(2S,3S,4R,5R)-5-(2,4-dioxopyri
  • beta-D-Allofuranuronamide, 1-deoxy-5-O-(4-deoxy-N-(hexahydro-2-oxo-1H-azepin-3-yl)-beta-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, (S)-
  • (2S,3S,4S)-2-((1R)-2-amino-1-((2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-3-methoxyoxolan-2-yl)-2-oxoethoxy)-3,4-dihydroxy-N-((3S)-2-oxoazepan-3-yl)-3,4-dihydro-2H-pyran-6-carboxamide
  • (2S,3S,4S)-2-((R)-2-Amino-1-((2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxoethoxy)-3,4-dihydroxy-N-((S)-2-oxoazepan-3-yl)-3,4-dihydro-2H-pyran-6-carboxamide
  • (2S,3S,4S)-2-[(1R)-2-amino-1-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-3-methoxy-tetrahydrofuran-2-yl]-2-oxo-ethoxy]-3,4-dihydroxy-N-[(3S)-2-oxoazepan-3-yl]-3,4-dihydro-2H-pyran-6-carboxamide
  • (2S,3S,4S)-2-[(R)-carbamoyl[(2S,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-4-hydroxy-3-methoxyoxolan-2-yl]methoxy]-3,4-dihydroxy-N-[(3S)-2-oxoazepan-3-yl]-3,4-dihydro-2H-pyran-6-carboxamide
  • (2S,3S,4S)-2-{(1R)-2-Amino-1-[(2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-3-methoxyoxolan-2-yl]-2-oxoethoxy}-3,4-dihydroxy-N-[(3S)-2-oxoazepan-3-yl]-3,4-dihydro-2H-pyran-6-carboxamide
  • (2S,3S,4S)-2-{(1R)-2-amino-1-[(2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl]-2-oxoethoxy}-3,4-dihydroxy-N-[(3S)-2-oxoazepan-3-yl]-3,4-dihydro-2H-pyran-6-carboxamide (non-preferred name)
  • (4S,5S,6S)-6-[(1R)-2-amino-1-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-3-methoxyoxolan-2-yl]-2-oxoethoxy]-4,5-dihydroxy-N-[(3S)-2-oxoazepan-3-yl]-5,6-dihydro-4H-pyran-2-carboxamide
  • (4S,5S,6S)-6-{(R)-Carbamoyl-[(2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-hydroxy-3-methoxy-tetrahydro-furan-2-yl]-methoxy}-4,5-dihydroxy-5,6-dihydro-4H-pyran-2-carboxylic acid ((S)-2-oxo-azepan-3-yl)-amide
  • (6-{(1R)[(2S,3S,4R,5R)-5-(2,4-Dioxo(1,3-dihydropyrimidinyl))-4-hydroxy-3-methoxyoxolan-2-yl]carbamoylmethoxy}(4S,5S,6S)-4,5-dihydroxy(4H-5,6-dihydropyran-2-yl))-N-((3S)-2-oxoazaperhydroepin-3-yl)carboxamide
  • .ALPHA.-L-TALOFURANURONAMIDE, 1-DEOXY-5-O-(4-DEOXY-N-((3S)-HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)-.BETA.-L-ERYTHRO-HEX-4-ENOPYRANURONAMIDOSYL)-1-(3,4-DIHYDRO-2,4-DIOXO-1(2H)-PYRIMIDINYL)-3-O-METHYL-
  • .ALPHA.-L-TALOFURANURONAMIDE, 1-DEOXY-5-O-(4-DEOXY-N-(HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)-.BETA.-L-ERYTHRO-HEX-4-ENOPYRANURONAMIDOSYL)-1-(3,4-DIHYDRO-2,4-DIOXO-1(2H)-PYRIMIDINYL)-3-O-METHYL-, (S)-
  • 1-[(5R)-3-O-Methyl-5-carbamoyl-5-O-[(2S)-3beta,4beta-dihydroxy-6-[[(3S)-2-oxohexahydro-1H-azepine-3beta-yl]carbamoyl]-3,4-dihydro-2H-pyran-2alpha-yl]-beta-D-ribofuranosyl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
  • 1-[5-O-[4,6-Dideoxy-6-oxo-6-[[[(3S)-hexahydro-2-oxo-1H-azepine]-3-yl]amino]-beta-L-erythro-4-hexenopyranosyl]-3-O-methyl-6-deoxy-6-amino-alpha-L-talofuranuronosyl]-1,2,3,4-tetrahydro-2,4-dioxopyrimidine
  • 1-DEOXY-5-O-(4-DEOXY-N-((3S)-HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)-.BETA.-L-ERYTHRO-HEX-4-ENOPYRANURONAMIDOSYL)-1-(3,4-DIHYDRO-2,4-DIOXO-1(2H)-PYRIMIDINYL)-3-O-METHYL-.ALPHA.-L-TALOFURANURONAMIDE
  • beta-D-Allofuranuronamide, 1-deoxy-5-O-(4-deoxy-N-(hexahydro-2-oxo-1H-azepin-3-yl)-alpha-L-erythro-hex-4-enopyranuronamidosyl)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, (S)-
  • NKM